This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WASHINGTON — The day drug makers dreaded has finally arrived. Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them. The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl
A long-time leader in public health and outreach to people of color, Dr. Reed Tuckson offers the lessons he learned from the COVID pandemic and how pharma can better serve those communities.
The National Institutes of Health said Thursday that an antiviral often used to treat mpox did not resolve patients’ symptoms faster than placebo in a randomized trial. The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its sporadic use over the years in parts of Africa and its wider use during the 2022 and 2023 outbreaks in the U.S. and Europe.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
People with disabilities are largely excluded from clinical trials that could benefit them because federal agencies have failed to update rules that govern how trials are conducted or neglected to enforce existing laws that protect disabled Americans against discrimination, a new report has found. The National Council on Disability, an independent federal agency, released the report this week detailing how several federal agencies implicitly and explicitly exclude people with disabilities from c
Modern medicine has an empathy problem. Artificial intelligence — done right — might be able to help ease it. Despite the proliferation of communication training programs over the past decade or two, doctors often fail to express empathy, especially in stressful moments when patients and their families are struggling to hear bad news and make difficult decisions.
The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.
As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions because Medicare doesn’t sufficiently cover far more convenient, and less distressing, at-home treatments with the arthritis drug Humira. When rheumatoid arthritis patients enroll in Medicare, switching from private insurance plans, self-administered medications such as Humira and Xeljanz become unaffordable overnight, thanks to the program’s convoluted pricing of at
The National Pharmacy Association (NPA) is ‘hopeful’ about the new government’s support for the sector, but is planning another day of action to keep pharmacy ‘on the agenda’. ‘The new government has had lots of issues to deal with in its first few weeks. We want to make sure that we remind the government this […] The post Paul Rees: 'We have to keep pharmacy on the government's agenda' appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m really excited to see “Alien: Romulus” this weekend, which I’m told harkens back to the 1979 original. Great 1970s-era sci-fi movies and TV series that are not Star Wars: Space 1999, Battlestar Galactica, Planet of the Apes, Close Encounters of the Third Kind, and Logan’s Run.
The UK Health Security Agency (UKHSA) has updated its guidance to advise health professionals to be aware of a new more fatal variant of mpox, currently spreading in parts of central and East Africa. The UKHSA warning, issued today, comes after the World Health Organization (WHO) declared mpox a global public health emergency yesterday. There are […] The post UKHSA updates mpox guidance for health professionals amid global health alert appeared first on The Pharmacist.
When demand for office space cratered during the Covid-19 pandemic, many developers in the Boston area doubled down on building lab space instead. Lately, it sure seems like they went overboard. With life sciences buildings hitting the market at a much faster rate than they can be filled, the region’s lab vacancy rate has skyrocketed, to the point that the share of empty space available rivals that of the pandemic-battered office market.
AI's role in inventing new drugs raises questions about ownership rights in the pharmaceutical sector. Explore the complexities of defining ownership in drug discovery with AI technology.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Lykos Therapeutics, whose MDMA-assisted psychotherapy for post-traumatic stress disorder was rejected late last week by U.S. regulators, announced Thursday that it would cut 75% of its staff, and that the company’s founder would step down from its board. “We take to heart the FDA’s decision and the additional work we will need to do to bring this pioneering therapy to market,” Jeff George, chairman of the board, said in a statement.
The U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening (anaphylaxis), in adult and pediatric patients who weigh at least 30 kilograms (about 66 pounds). "Today's approval provides the first epinephrine product for the treatment of anaphylaxis that is not administered by injection.
The U.S. Department of Health and Human Services has stated it will do all that it can to mitigate the health care industry’s greenhouse gas emissions. The evidence suggests it is climate washing. Climate washing is defined as a government or business providing inadequate, inaccurate, misleading, or false public information about its climate policy ambitions or implementation efforts to reduce greenhouse gas emissions, especially when the claims are made without independent third-party as
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
A widespread, monthslong contract dispute between UnitedHealthcare and Trinity Health has created a confusing patchwork of disrupted access across multiple states. UnitedHealthcare is the country’s largest health insurer, so its contract disagreements with large health systems affect members across the country from one another, threatening access to dozens of hospitals and their affiliated physicians.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Big news this morning, so let’s get straight into it.
The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Almost exactly two years ago, the Inflation Reduction Act was signed into law, allowing Medicare to negotiate drug prices for the first time. Today, the agency announced how much it lowered the costs for 10 drugs in the first year of negotiation.
Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and recent publication retractions pull down the entire psychedelics industry? And what would you name a commercial psychotherapy treatment? We discuss all that and more on this week’s episode of “The Readout LOUD.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Tonix Pharmaceuticals has announced promising phase 3 trial results for TNX-102 SL (sublingual cyclobenzaprine HCl), a treatment targeting fibromyalgia.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
363 
Let's personalize your content